Dehui Zou

Tianjin University of Technology — China

Medicine · Health Sciences

29h-index3.1kcitations511works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Multiple Myeloma Research and Treatments(195), Chronic Lymphocytic Leukemia Research(174), Lymphoma Diagnosis and Treatment(150), Chronic Myeloid Leukemia Treatments(78), CAR-T cell therapy research(53)

Publications511 total

Associations of weight-adjusted waist index with cardiovascular chest pain risk in U.S. adults
Journal of Health Population and Nutrition·2025Open Access
USF++: A Unified Sampling Framework for Solver Searching of Diffusion Probabilistic Models
IEEE Transactions on Pattern Analysis and Machine Intelligence·2025Open Access
Sex-Specific Associations Between Anthropometric Indices and Left Ventricular Hypertrophy in Middle-Aged and Elderly Individuals with Type 2 Diabetes Mellitus
Diabetes Metabolic Syndrome and Obesity·2025Open Access
Ibrutinib alternating with three cycles of interval fludarabine, cyclophosphamide, and rituximab (FCR) in adults with untreated chronic lymphocytic leukaemia as time-limited regimen: a single-arm, multicentre phase 2 trial in China
EClinicalMedicine·2025Open Access
Type I Interferon Pathway Activation Disrupts Monocyte Maturation and Enhances Immune Evasion in Multiple Myeloma
Advanced Science·2025Open Access
First-in-human trial of GT719, a novel stem cell-derived allogeneic anti-CD19 CAR-iNKT cell therapy for relapsed/refractory B cell malignancies
Blood·2025Open Access
Combining axicabtagene ciloleucel (axi-cel) or relmacabtagene autoleucel (relma-cel) with HDT/ASCT in relapsed/refractory large B-cell lymphoma: A single-center experience
Blood·2025Open Access
Equecabtagene autoleucel in patients with relapsed or refractory multiple myeloma: The first real-world data from a single Chinese center
Blood·2025Open Access
Pola-R-edch shows high response rates in high-risk aggressive B-cell lymphomas or PMBCL: A phase 2 study
Blood·2025Open Access
SOUNDTRACK-F1: A phase 3, randomized, open-label study of surovatamig (AZD0486) plus rituximab versus chemotherapy plus rituximab in patients with previously untreated follicular lymphoma
Blood·2025Open Access
Prognostic significance of clinical risk models and genomic alterations in Waldenström macroglobulinemia before or after BTK inhibitor era
Blood·2025Open Access
Efficacy and safety of mitoxantrone hydrochloride liposome in peripheral T-cell lymphoma: A multicenter, non-interventional, ambispective cohort real-world study
Blood·2025
Promising safety and efficacy of equecabtagene autoleucel (eque-cel) followed ASCT in ultra high-risk multiple Myeloma (UHR-MM) patients: primary real world data from a single center
Blood·2025Open Access
Integration of longitudinal ctdna MRD and PET/CT enhances prognostic stratification in newly diagnosed diffuse large B-cell lymphoma: A prospective multicenter study
Blood·2025
Effectiveness and safety of axicabtagene ciloleucel (Axi-cel) in Chinese patients with relapsed/refractory non-Hodgkin lymphoma: Age subgroup analysis of real-world study
Blood·2025
Preliminary analysis of orelabrutinib combined with obinutuzumab in the treatment of marginal zone lymphoma (Orion Study)
Blood·2025Open Access
Association between stress hyperglycemia ratio and all-cause mortality in patients with acute kidney injury: a retrospective analysis of the MIMIC-IV database using machine learning
BMC Nephrology·2025Open Access
The New Learned Index for LSM-Tree
2025
Effect of bone marrow mononuclear cells therapy on long-term survival of patients with liver cirrhosis: A 10-year retrospective cohort study using propensity score matching
Journal of Translational Internal Medicine·2025· 1 citedOpen Access
DC-VideoGen: Efficient Video Generation with Deep Compression Video Autoencoder
arXiv (Cornell University)·2025Open Access
page 1 of 26Next →

Frequent Co-authors

Lugui Qiu(31), Shuhua Yi(21), Yan Xu(20), Gang An(20), Shuhui Deng(19), Weiwei Sui(19), Mu Hao(15), Zengjun Li(15), Jianxiang Wang(13), Wei Liu(10), Rui Lv(10), Tao Cheng(9), Zhen Yu(9), Haiyan Yang(8), Huilai Zhang(7), Yu‐Tzu Tai(7), Keshu Zhou(6), Jianfeng Zhou(6), Fangfang Lv(6), Jun Zhu(6)